期刊文献+

补肾健脾消症方联合化疗治疗胃癌术后患者疗效观察 被引量:7

Bushenjjianpixiaozheng Prescription Combination Chemotherapy Treatment Stomach Postoperative Patients
下载PDF
导出
摘要 目的:探讨补肾健脾消症方对胃癌术后患者化疗过程中细胞免疫功能和生存质量的影响。方法:将60例胃癌术后患者随机分为单纯化疗组和联合化疗组各30例,并与健康对照组比较,观察化疗前后NK细胞活性、CD3+、CD4+、CD8+、CD4+/CD8+比值,以及生存质量评分(Karnofky评分)情况。结果:1、与健康对照组比较,胃癌术后患者NK细胞活性、CD3+和CD4+显著降低(P<0.05),而CD8+明显升高(P<0.05),致CD4+/CD8+比值降低(P<0.01);2、同组治疗前后比较,单纯化疗组治疗后NK细胞活性、CD3+降低明显(P<0.05)。两组治疗后比较,联合化疗组NK细胞活性、CD8+高于单纯化疗组(P<0.05),在CD3+、CD4+、CD4+/CD8+比较上差异更为明显(P<0.01);3、同组治疗前后比较,联合化疗组治疗后Karnofky评分明显高于治疗前(P<0.05),而单纯化疗组治疗前后无明显变化。两组治疗后比较,联合化疗组Karnofky评分明显高于单纯化疗组(P<0.01)。结论:补肾健脾消症方可显著提高胃癌术后患者化疗过程中的细胞免疫功能和生存质量。 Objective:To explore the Bushenjianpixiaozheng (BSJPXZ) prescription in patients with operation chemotherapy process and quality of life of the cellular immune function. Methods:60 cases were randomly divided into pure chemotherapy group and combination chemotherapy groups. Compared with healthy group,and observe the NK cell activity and ratio of CD3^+,CD4^+,CD8 +,CD4^+ / CD8^+ ,and quality of life score (Karnofky score). Results:First,Compared with healthy controls,NK cell activity ,CD3^+,CD4 + significantly reduced (P〈0.05),and CD8^+ increased significantly (P 0.05),cause CD4 + / CD8^+ ratio lower (P〈0.01). Second,the comparison group before and after treatment,the pure chemotherapy group after treatment,CD3^+,NK cells activity reduced significantly (P〈0.05). Two groups after treatment with combination chemotherapy group,NK cell activity,CD8^+ higher than pure chemotherapy group (P〈0.05),CD3^+,CD4^+,CD4^+ / CD8^+ is more obvious difference (P〈0.01).Third,before and after the treatment group,combination chemotherapy treatment group was obviously higher than the pure chemotherapy group has no obvious changes before and after treatment by Karnofky score (P〈0.05). Two groups after treatment with combination chemotherapy group,Karnofky score significantly higher than the pure chemotherapy group (P〈0.01). Conclusion:BSJPXZ prescriptioncan significantly improve the process of chemotherapy patients after operation in cellular immune function and quality of life.
出处 《中华中医药学刊》 CAS 2010年第8期1781-1783,共3页 Chinese Archives of Traditional Chinese Medicine
关键词 胃癌术后 化疗 补肾健脾消症方 细胞免疫功能 Karnofky评分 stomach surgery chemotherapy cellular immune function Karnofky score
  • 相关文献

参考文献6

  • 1汤钊猷主编..现代肿瘤学 第2版[M],2000:1507.
  • 2中国抗癌协会..新编常见恶性肿瘤诊治规范 鼻咽癌分册[M],1998.
  • 3Shirraishi N, Inomata M, Osawa N, et al. Early and late recurrence after gastrectomy for gastric carcinoma[ J]. Cancer,2002, 89:255 - 261. 被引量:1
  • 4郝天玲,张桂梅,冯作化,张慧,姜志尧.几种肿瘤免疫抑制因子作用的研究[J].同济医科大学学报,1995,24(2):105-108. 被引量:7
  • 5Marubayashi M,Solana R,Ramirez R,et al. Sera from patients with colon,breast and lung cancer induce restance to lysis mediated by NK cytotoxic factor(NKCF)[J]. Br J Cancer,1991,63:893. 被引量:1
  • 6王本祥主编..现代中药药理与临床[M].天津:天津科技翻译出版公司,2004:1781.

共引文献6

同被引文献120

引证文献7

二级引证文献84

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部